We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+14.5%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.78B
AUM Growth
-$305M
(-4.3%)
Cap. Flow
-$1.04B
Cap. Flow
% of AUM
-15.36%
Top 10 Holdings %
Top 10 Hldgs %
29.21%
Holding
1,363
New
346
Increased
312
Reduced
313
Closed
357
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Perrigo
PRGO
|
+$251M |
| 2 |
AGN
Allergan plc
AGN
|
+$209M |
| 3 |
Cigna
CI
|
+$106M |
| 4 |
ESPR
Esperion Therapeutics
ESPR
|
+$77.7M |
| 5 |
Labcorp
LH
|
+$52.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$368M |
| 2 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$354M |
| 3 |
ENDP
Endo International plc
ENDP
|
+$331M |
| 4 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$224M |
| 5 |
Brookdale Senior Living
BKD
|
+$155M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.37% |
| 2 | Consumer Discretionary | 6.42% |
| 3 | Industrials | 5.53% |
| 4 | Financials | 5.32% |
| 5 | Technology | 5.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Automatic Data Processing
ADP
$107B
| $527K | 0.01% |
6,157
-8,610
| -58% | -$741K |
|
|
LLTC
652
DELISTED
Linear Technology Corp
LLTC
| $526K | 0.01% |
11,241
-14,066
| -56% | -$659K |
|
653
Arbutus Biopharma
ABUS
$861M
| $524K | 0.01% |
+30,000
| New | +$615K |
|
|
CHK
654
PUT
DELISTED
Chesapeake Energy Corporation
CHK
| $524K | 0.01% |
+15
| New | +$52.9K |
|
655
Enerpac Tool Group
EPAC
$1.85B
| $522K | 0.01% |
21,980
-8,514
| -28% | -$209K |
|
|
DNY
656
DELISTED
DONNELLEY R R & SONS CO
DNY
| $519K | 0.01% |
27,051
+3,151
| +13% | +$60.5K |
|
657
Southern Company
SO
$107B
| $518K | 0.01% |
11,700
-851
| -7% | -$40.4K |
|
|
ARMH
658
DELISTED
ARM HOLDINGS PLC ADS
ARMH
| $517K | 0.01% |
+10,485
| New | +$522K |
|
|
XLNX
659
DELISTED
Xilinx Inc
XLNX
| $516K | 0.01% |
12,200
-17,075
| -58% | -$700K |
|
660
NOV
NOV
$6.94B
| $515K | 0.01% |
10,300
-2,660
| -21% | -$144K |
|
661
JB Hunt Transport Services
JBHT
$25.1B
| $513K | 0.01% |
6,008
+978
| +19% | +$81.8K |
|
662
Loews
L
$23.9B
| $510K | 0.01% |
12,500
-200
| -2% | -$8.1K |
|
663
Franklin Resources
BEN
$18.3B
| $495K | 0.01% |
9,643
-3,056
| -24% | -$162K |
|
664
Conagra Brands
CAG
$7.14B
| $491K | 0.01% |
17,265
-42,396
| -71% | -$1.17M |
|
665
Huntington Bancshares
HBAN
$35.1B
| $491K | 0.01% |
+44,438
| New | +$469K |
|
666
Celldex Therapeutics
CLDX
$2.96B
| $485K | 0.01% |
+1,160
| New | +$415K |
|
667
United Therapeutics
UTHR
$25.7B
| $483K | 0.01% |
2,800
+100
| +4% | +$15.2K |
|
668
Booking.com
BKNG
$149B
| $482K | 0.01% |
10,350
+2,850
| +38% | +$128K |
|
669
Wayfair
W
$11.8B
| $482K | 0.01% |
+15,000
| New | +$373K |
|
|
MTBL
670
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
| $482K | 0.01% |
+133,333
| New | +$511K |
|
671
Berkshire Hathaway Class B
BRK.B
$1.11T
| $476K | 0.01% |
3,300
+894
| +37% | +$132K |
|
672
Avient
AVNT
$3.43B
| $471K | 0.01% |
12,616
-6,298
| -33% | -$239K |
|
673
Ambev
ABEV
$47.1B
| $470K | 0.01% |
+81,605
| New | +$507K |
|
674
KBR
KBR
$4.68B
| $470K | 0.01% |
32,454
+18,797
| +138% | +$306K |
|
675
Stratasys
SSYS
$706M
| $469K | 0.01% |
8,886
-54,355
| -86% | -$3.6M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q1 2015 Portfolio in Review
As of Q1 2015, Visium Asset Management held 1,363 positions worth $6.78B, down 4.3% from $7.08B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Visium Asset Management withdrew a net $1.04B in Q1 2015, closing 357 positions and reducing 313 holdings. Its most notable exit was Allergan Inc, an estimated $368M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, up from 47% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Visium Asset Management opened a new position in Akorn Inc worth $25.3M.
- Visium Asset Management's largest Q1 2015 buy was Akorn Inc: 533,000 shares worth $25.3M.
- Visium Asset Management added most to Perrigo in Q1 2015, an estimated $251M increase.
- Visium Asset Management's biggest Q1 2015 reduction was Endo International plc, cutting an estimated $331M.
- Visium Asset Management fully exited Allergan Inc in Q1 2015, selling an estimated $368M.
- Visium Asset Management's ten largest holdings make up 29% of its $6.78B portfolio in Q1 2015.
- Visium Asset Management opened 346 new positions and closed 357 in Q1 2015.
- Visium Asset Management's portfolio value fell 4.3% quarter-over-quarter to $6.78B.
Based on Visium Asset Management's 13F filing for Q1 2015, filed 15 May 2015.